13-08-2026 17:10 via drugs.com

2005 to 2023 Saw Decrease in DXA Testing for Osteoporosis Screening

THURSDAY, Aug. 13, 2026-- From 2005 to 2023, there was a decrease in dual-energy X-ray absorptiometry (DXA) testing for osteoporosis among Medicare beneficiaries, with the largest decrease seen for Hispanic beneficiaries, according to a study...
Read more »

Pharmaceutical Industry news



Burnout Common Among Psychiatric Mental Health Registered Nurses
FDA Approves First Self-Balancing, Personal Exoskeleton
Suboptimal Adherence to Brain Health Recommendations Common in Early Alzheimer Disease
Genomic Newborn Screening Could ID Cancer Predisposition Syndrome
Report Highlights Substance Use in Young Adults in U.S. in 2025
Imaging Turnaround Time Increased From 2023 to 2024
Many With Atypical Alzheimer Disease Do Not Qualify for Anti-Amyloid Therapy
Stair Climbing Associated With Reduction in Cardiovascular, All-Cause Mortality
Socioeconomic Inequalities Tied to Functional Aging
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay
First Metatarsophalangeal Joint Arthrodesis Eases Painful Hallux Rigidus
Menopausal Hormone Therapy Use Linked to Lower Risk for Alzheimer Disease
Study IDs Neurobiological Roots of Sensory Over-Responsivity
Endometriosis Tied to Higher Risk for Developing Type 2 Diabetes
Desktop versie